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Diabetic emergencies include a group of conditions in which an elevated or diminished glucose level exists. This 
can result in metabolic emergencies causing patients to present with an array of symptoms including severe 
abdominal pain, shortness of breath, and even altered mental status.[1] The acute metabolic complications of 
diabetes (diabetic ketoacidosis (DKA), hyperosmolar hyperglycaemic state (HHS), and hypoglycaemia) occur 
frequently in Africa. Factors such as non-compliance with medication, late presentation, and lack of access to 
health facilities lead to delays in the diagnosis and management of these complications.[1] These life-threatening 
emergencies carry high morbidity and mortality and require prompt lifesaving interventions. These interventions 
are not always possible due to a combination of factors including inadequate access to health services, poor 
health-seeking behaviour and overburdened health care facilities.[1] 
The rapid increase in the prevalence of diabetes in developing countries seems secondary to the effect of 
westernization, although the prevalence varies between regions. It is thus imperative to establish local trends in 
order to facilitate future health care planning.[2] Socio-economic circumstances, infections and access to health 
care are some of the known factors affecting disease outcome and progression. These factors do not always apply 
to high-income countries (HICs) where most of the currently available data originates from. It is thus important 
to collect data that is relevant to low-and middle-income-countries (LMICs) in order to facilitate better health 
care for all. 
The goal of this literature review was to discern the burden of diabetic emergencies. Academic literature was 
comprehensively searched for articles related to diabetes and its complications. The review is divided into 
diabetes mellitus in general, diabetic emergencies (DKA, HHS, uncomplicated hyperglycaemia, severe 
hypoglycaemia), and the burden of diabetic emergencies on the emergency centre. The information within each 
diabetic emergency is presented according to the definition, prevalence, risk factors, clinical presentation, 





Diabetes can be divided into different subgroups, which include type 1 diabetes mellitus (T1DM) and type 2 
diabetes mellitus (T2DM). T1DM is a result of autoimmune destruction of pancreatic beta cells, causing an 
absence of insulin. Treatment regimes, therefore, aim to correct the insulin-deficient state, typically by exogenous 
insulin replacement. T2DM can be defined as insulin resistance, and to a degree, insulin release defects, in which 
genetic, lifestyle and environmental factors play a role. Historically it was only thought to occur in middle-aged 
to older patients; however, younger patients are being diagnosed more frequently. The clinical presentation of 
T2DM is similar to T1DM, but patients can go undiagnosed for long periods of time as the presenting symptoms 
are generally less severe. Management regimes involve the reduction of glucose levels by oral anti-glycaemic 
agents and exogenous insulin replacement.[3] 
The current global prevalence of diabetes is 9.3%, with a higher prevalence occurring in HICs (10.4%) compared 
to middle-income countries (9.5%) and low-income countries (4%). The prevalence of diabetes in Africa is 
reported to be 3.9%; while South Africa has a slightly higher prevalence of 5.4%. It is expected that LMICs will 
experience an excessive rise in diabetes prevalence over the next 25 years.[4] 
T2DM occurs more frequently than T1DM as reported by both the International Diabetes Federation and the 
Centre for Disease Control and Prevention (CDC) in the United States (US).[2,5] In 2000-2014, the prevalence of 
T2DM in the US was 8.6% compared to 0.55% of T1DM.[6] 
The prevalence of diabetes (and the two subgroups) is variable and changes according to geographical location, 
age, and socio-economic status.[2] It is estimated that more than two-thirds of people living with diabetes are 
from LICs, despite the low reported prevalence of diabetes in these countries.[4] Roughly half of the people living 
with diabetes are oblivious to the diagnosis, with Africa having the highest number of undiagnosed cases.[2] In 
keeping with global data, T2DM is more prevalent than T1DM in Sub-Saharan Africa. 
Urban populations have a higher prevalence than rural populations (10.8% versus 7.2%), and this difference was 
also documented in South Africa in 2016.[2,7] Differences due to age is also noticeable with the prevalence in 
HICs peaking in older patients (>75 years old); while the prevalence in LMICs peaks in younger age groups.[2] 
The prevalence also differs between income levels, where the less affluent had a prevalence of 9% compared to 
4.3% in the more affluent group.[8] A direct link between poverty and a higher prevalence of T2DM has also been 
documented.[9] 
Diabetes is notorious for its systemic effect on the human body. A wide array of diabetes-related complications 
exist, which can be divided into curable (DKA, HHS and hypoglycaemia) and incurable (macrovascular and 
microvascular complications) complications.[2,3,10] Macrovascular complications include an umbrella of 
conditions such as coronary artery disease, cerebrovascular disease and peripheral artery disease. Microvascular 
complications include nephropathy, retinopathy and neuropathy.[2] All of these complications are linked to a 
decrease in quality of life and life expectancy.[3] 
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Worldwide diabetes is responsible for about 11.3% of deaths, most of them occurring in the economically active 
population.[5] In Africa, 75% of diabetic-related deaths occurred in people younger than 60 years old.[2] Diabetes 
is also one of the leading causes of natural deaths amongst South Africans;[11] in 2016, diabetes contributed to 
7.2% of deaths amongst women and 4.0% of deaths in males.[12] 
Diabetes and its complications remain a massive health issue and concern, despite many enhancements in health 
care services around the world. 
 
Diabetic emergencies 
Diabetic emergencies can be divided into conditions with increased glycaemic states (DKA, HHS and 
symptomatic uncomplicated hyperglycaemia) and decreased glycaemic states (hypoglycaemia). 
Diabetic ketoacidosis (DKA) 
Definition 
The American Diabetes Association (ADA) and the Society for Endocrinology, Metabolism and Diabetes of 
South Africa (SEMDSA), define DKA using the following criteria: i) Hyperglycaemia (plasma glucose >13.9 
mmol/L), ii) Acidosis (blood pH <7.3 or bicarbonate <18 mmol/L), and iii) Ketonemia (blood beta-
hydroxybutyrate > 3 mmol/L).[3,10] The severity of DKA can be categorized according to the blood pH level into 
mild (7.25 - 7.3), moderate (7.0 - 7.24), and severe (<7.0) categories.[3,10] 
Prevalence 
The number of patients presenting with DKA in the US and the United Kingdom (UK) has been increasing. The 
CDC reported an age-adjusted increase of DKA hospitalizations in the US from 2000 through 2014; the rate 
increased by 54.9%, from 19.5 to 30.2 per 1000 persons.[5] A similar increase also occurred in Canadian children 
with T1DM where the age- and sex-standardized rate of DKA increased 7.6% from 22% between 2001 and 
2014.[13] The true prevalence of DKA in Africa and South Africa remains undetermined. 
Risk factors 
DKA is a frequent complication of diabetes globally and most often occurs in patients with T1DM.[14] Patients 
with T2DM are also susceptible to DKA under stressful conditions, e.g. trauma or surgery.[15] South African data 
similarly indicate the higher prevalence in T1DM patients (61% compared to 39% in T2DM); however one study 
reported a higher prevalence in T2DM (54% versus 47% in T1DM.[16,17]  
No sex preference seems to be associated with DKA. In a UK based study, interrogating three groups (one 
admission, two to five admissions and greater than five admissions), no significant difference was seen across all 
of these groups. In those who presented with more than five admissions, no statistical significance was seen 
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(women 26% compared to men 21.7% (p=0.186)); similar results were documented in South Africa (male 51%; 
female 49%).[17,18] 
Poor socio-economic circumstances, younger age, and antidepressant use or psychiatric comorbidity are other 
risk factors for DKA.[8,15,17–19] 
Clinical presentation 
The clinical presentation of DKA is not always easily recognised, as a large proportion of patients present with 
non-specific signs and symptoms.[17,20] The clinical presentation may include polyuria, polydipsia, 
gastrointestinal symptoms (nausea, vomiting, abdominal pain), visual disturbance, lethargy, tachycardia, 
shortness of breath, and altered sensorium.[17,21,22] Gastrointestinal symptoms are frequently reported when 
patients present with DKA and is present between 51% and 74% of the time.[17,23,24] Physical findings may also 
include Kussmaul breathing and features of hypovolemic shock.[3] 
Precipitants 
Non-compliance and infection are the commonest precipitants in DKA admissions, while other causes include 
concurrent illnesses (i.e., trauma, myocardial ischemia).[3,25] A study in the US reported medication omission as 
a reason for presentation in 90% of the study population, while a small North Indian study reported non-
compliance in more than 50% of patients.[23,24] Non-compliance is also a frequent cause of DKA in South Africa, 
ranging between 27% and 32%.[17,26] Concurrent infection is the other major cause of DKA in diabetic patients 
and were present in 36% to 38%; both internationally and within South Africa.[23,24,26] In reality, no precipitant 
can be identified in a substantial proportion of patients. 
Investigations 
Recommended bedside and laboratory evaluation of patients with DKA should be aimed at confirming the 
diagnosis and identifying the cause and potential complications of the disease.3 This includes measuring the 
glucose level (serum glucose or finger prick), the presence of ketones (serum and urinary ketones), assessment of 
dehydration (serum urea and serum creatinine), and the presence of electrolyte derangement, which can be seen 
on blood gas and renal function test.3 
The osmolality and anion gap should be calculated as it assists with determining the degree of acidosis and 
dehydration, in addition, it can assist with measuring trends. The osmolality gives an indication of the degree of 
dehydration and can also be used to distinguish DKA from HHS, which is usually associated with a higher 
osmolality (>320mmol/l). The anion gap is a measurement of ions in the body and DKA is usually associated 
with a high anion gap (>12mEq/L). Narrowing of the anion gap in a DKA patient is reassuring and a sign of 
improvement.3 
Measuring for the presence of ketonemia is important, as it helps to discern the type of diabetic      emergency 
in hyperglycaemic patients. As serum ketone tests are not everywhere readily available, the presence of ketones 
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in the urine (ketonuria) is often used as a surrogate marker.[2,3] However, there are two ketones playing a role in 
the acidosis of a DKA, acetoacetate and beta-hydroxybutyrate (the latter being the predominant ketone in severe 
untreated DKA). Acetoacetate is detected by the urine dipstick, but beta-hydroxybutyrate is not;[27] with the 
potential to miss the diagnosis of DKA. A US-based study found a similar sensitivity for blood beta-
hydroxybutyrate strips and urine acetoacetate dipsticks (both 98%) in diagnosing DKA, but blood beta-
hydroxybutyrate strips had higher specificity (79%) than the urine acetoacetate dipsticks (35%).[28] This 
decreased specificity raises concerns of potentially unwarranted medical work-ups as a result of false-positive 
tests. Similarly, a systematic review indicated that measuring serum beta-hydroxybutyrate was found to be more 
effective than urine acetoacetate, leading to a reduction in hospitalization and shorter time to resolution.[28] Beta- 
hydroxybutyrate strips have the advantage of being used at the point of care and is an affordable alternative to 
serum beta‐hydroxybutyrate.[29] The use of urine dipsticks compared to serum ketones as the primary detection 
mode of ketone bodies is often used in low resourced settings, and health care personnel should understand the 
potential diagnostic pitfalls. 
Additional investigations should include an electrocardiogram (ECG) and a chest X-ray. Both these 
investigations can assist in diagnosing the precipitant cause and in monitoring management; ECG to evaluate for 
ischaemic events and the effect of electrolyte derangements, and chest X-ray to identify pulmonary infections 
and features of fluid overload. Further selective case-based testing should be aimed at determining the reason 
for presentation, e.g. an abdominal ultrasound for appendicitis, mesenteric ischaemia, and gallbladder 
pathology.[30,31] 
Management 
Globally, similar pathways are followed for the management of patients with DKA. The cornerstone of 
management includes restoration of fluid depletion, resolving the acidosis, monitoring and correcting potassium 
abnormalities, and managing precipitating causes.[17,22,32,33] 
The infusion of fluids improves the intravascular volume and restore perfusion.[32] Patients presenting in DKA 
have an estimated fluid deficit between 5 and 10 litres. The ideal fluid type remains a contentious subject for 
debate, both internationally and locally. Both the US and UK accept the use of normal saline as the initial fluid 
replacement of choice,[33] while South African protocols recommend either normal saline solution or ringer’s 
lactate.[3,21] A small trial in South Africa, found no difference in the time it took for the pH no normalise (pH = 
7.32) between ringer's lactate (540 minutes (95% confidence interval (CI) 184-896)) and normal saline (683 
minutes (95% CI 378-988)) as the primary Additional investigations should include an electrocardiogram (ECG) 
and a chest X-ray. Both these investigations can assist in diagnosing the precipitant cause and in monitoring 
management; ECG to evaluate for ischaemic events and the effect of electrolyte derangements, and chest X-ray 
to identify pulmonary infections and features of fluid overload. Further selective case-based testing should be 
aimed at determining the reason for presentation, e.g. an abdominal ultrasound for appendicitis, mesenteric 




Globally, similar pathways are followed for the management of patients with DKA. The cornerstone of 
management includes restoration of fluid depletion, resolving the acidosis, monitoring and correcting potassium 
abnormalities, and managing precipitating causes.[17,22,32,33] 
The infusion of fluids improves the intravascular volume and restore perfusion.[32] Patients presenting in DKA 
have an estimated fluid deficit between 5 and 10 litres. The ideal fluid type remains a contentious subject for 
debate, both internationally and locally. Both the US and UK accept the use of normal saline as the initial fluid 
replacement of choice,[33] while South African protocols recommend either normal saline solution or ringer’s 
lactate.[3,21] A small trial in South Africa, found no difference in the time it took for the pH no normalise (pH = 
7.32) between ringer's lactate (540 minutes (95% confidence interval (CI) 184-896)) and normal saline (683 
minutes (95% CI 378-988)) as the primary resuscitation fluid (p = 0,251).[34] The choice of fluid after the initial 
volume replacement depends on the patient’s hydration status, serum electrolyte levels, and the glucose level. 
Insulin inhibits the ketogenic pathway. Short-acting insulin is recommended as a continuous insulin infusion at 
a rate of 0,14 units/kg/hour in a high care or intensive care setting with intensive glucose monitoring.[35,36] 
Different routes of insulin therapy exist, such as continuous intravenous (IV) infusion, bolus IV, subcutaneous 
(SC) or intramuscular (IM) insulin therapy.[16] In a recent study, a bolus IV insulin regime was successfully used 
as the primary treatment modality in managing patients with DKA.[16] The rationale behind this method of 
managing DKA stems from an anticipated cost and resource benefit in managing patients outside of the intensive 
care setting, which is vital in low resource environments.[16] Most protocols recommend changing to subcutaneous 
insulin only when the hyperglycaemic emergency has resolved, however successful management of mild cases 
with regular subcutaneous bolus regimes has been documented.[3,16,22] 
Blood ketone testing is a useful parameter in managing DKA patients, as the resolution of acidosis is usually 
represented by the reduction of ketonemia and thus is a valuable tool to measure improvement.[37] 
Potassium levels should be strictly monitored, and potassium should be replaced if needed. If the initial potassium 
is less than 3.5 mmol/l, potassium should be replaced before initiating the insulin infusion. This is recommended 
to avoid severe hypokalaemia (insulin drives potassium intracellular) and its complications, such as arrhythmias 
or respiratory muscle weakness. Potassium levels should be monitored 4-hourly to guide the need for further 
replacement.[3,38] 
The use of bicarbonate is not routinely recommended.[31,39] However, the ADA guidelines do suggest using 
bicarbonate when the serum pH is less than 6.9 until it reaches no higher than 7. Although there is insufficient 
data to prove the value of bicarbonate, the theory behind its use is to assist with lessening the severe acidotic state, 
which is associated with life-threatening organ dysfunction.[10,30] 
Patients with moderate to severe DKA require intense monitoring, ideally in a high care setting or intensive care 
unit (ICU). In reality, high care and ICU beds are not available in all hospitals,[3,40] and these patients are often 
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cared for in the emergency centre.[41] However, the treatment and management of diabetic emergencies should 
not be delayed or affected when scarcity of high care or ICU beds exist, as this can lead to high morbidity and 
mortality. 
Resolution 
The ADA defines the resolution of DKA as maintaining normoglycaemia (blood glucose level < 11.1 mmol/L), 
absent ketonemia and acidosis resolution (bicarbonate ≥15 mEq/L, pH >7.3, and anion gap  
≤12 mEq/L)[10] Time to resolution could be seen as a surrogate of efficacy in managing diabetic emergencies,18 
although the length of hospital stay varies depending on the institution and the specific management protocol. In 
an Australian retrospective audit between 2010 to 2014, it took around 11 hours for DKA to resolve;[42] which 
was similar to a retrospective study done in the UK in 2012.[43] Contrary, an Ethiopian based study reported a 
significantly longer time to resolution (2.7 days ± 3 days); however, participants were primarily managed in a 
medical ward with ward friendly protocols.[44] The median time to resolution at a tertiary hospital in South Africa, 
using IV hourly insulin boluses, was 21 hours.[16] 
The length of hospital stay varies between 2 and 8 days and are influenced by factors such as comorbidities, 
precipitants, and the setting.[23,43,45] A study by Umpierrez et al. demonstrated the importance of comorbidities; 
those who presented with non-compliance had a length of stay of 3.1 ± 1.6 days compared to 7.2 ± 3 days in 
those who had an underlying medical condition.[45] Studies from South Africa indicate an extended length of stay, 
with 8.9 ± 7.5 days documented in the KwaZulu/Natal province and 7-9 days in the Eastern Cape province (7-9 
days).[17,46] Striving to decrease hospital length of stay is an essential goal in resource-limited environments. 
Mortality 
Worldwide diabetes (in general) is responsible for about 11.3% of deaths, most of them occurring in the 
economically active population.[5] The exact mortality rate for DKA is unclear, but varies considerably. Mortality 
rates in Scotland have been under 0.2%,[18] in contrast to 8% in Zambia and 30% in Kenya.[47,48] The mortality 
rate also differ widely within South Africa; 8% in the Western Cape province,[26] 17% in KwaZulu/Natal,[17] and 
20% in the Eastern Cape province.[49] 
Various factors are associated with increased mortality risk. The presence of elevated serum urea levels, renal 
failure in general and altered mental status put patients at an increased risk of death.[47,50] Patients with recurrent 
admissions for DKA also have an increased risk of death. The mortality for patients who had one DKA admission 
over a median of 2.4 years was substantially lower than those with recurrent DKA admissions (5.2% versus 





Hyperosmolar hyperglycaemic state (HHS) 
A considerable amount of overlap exists between hyperglycaemic emergencies. The review on HHS and 
uncomplicated hyperglycaemia will therefor mainly highlight the differences to DKA, which was extensively 
described above. 
Definition 
HHS usually develops over a long period (several days to weeks) and is characterised by severe hyperglycaemia 
(serum glucose >33.3 mmol/L), hyperosmolality (serum osmolality >320 mOsm/kg), marked dehydration and 
the absence of significant acidosis (pH> 7.3, bicarbonate >15 mEq/L). Ketonuria may be slight or absent. 
Complications may result from the metabolic crises itself or the related dehydration and include seizures, arterial 
occlusion, deep vein thrombosis, rhabdomyolysis, and life-threatening electrolyte disturbances.[3,10] 
Prevalence 
HHS accounts for fewer diabetic-related admissions than DKA.[45] In a retrospective study, HHS only accounted 
for 3.3% of diabetic emergency-related admissions in the US,[52] whereas 12% of patients who presented with a 
diabetic emergency in a South African study had HHS.[53] HHS typically present in the middle-aged or older 
patients, but cases have been described in paediatric and adolescent groups.[54] 
Risk factors 
Older patients and patients with T2DM are at highest risk of developing HHS. The use of diuretics together with 
restricted water intake predispose the elderly to dehydration and ultimately HHS.[3] 
Clinical presentation 
Patients with DKA and HHS present similarly,[3,38,55], although neurological symptoms and signs occur more 
often in the HHS group. The change in mental status can vary from mild confusion to profound lethargy or coma, 
with a lower level of consciousness being linked to a higher osmolality (>340mOsm/kg).[56] Other neurological-
related presentations may include seizures and focal neurological signs, although it might rather point towards a 
possible underlying condition instead of the metabolic derangement.[3] 
Precipitants 
HHS may be brought on by infection, other illnesses (e.g. myocardial infarction or stroke), the concomitant use 
of medications that either decrease the effect of insulin or increase fluid loss and poor management of diabetes 
(including non-compliance to medication and diabetic diet). The most frequent precipitant is an infection, with 
rates documented to be as high as 57%.[55] The most common infection sites are pulmonary and urinary tract.[24,38] 
Management 
The management of HHS and DKA are very similar, and many societies have adopted a single treatment guideline 
for the management of these diabetic emergencies.[3,10] The treatment principles are fluid replacement, correction 
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of hyperglycaemia, electrolyte management, and finding (and treating) the cause. Prophylactic antithrombotic 
treatment should also be considered. 
The same fluid regime as for DKA can be used if there is no cardiac compromise (1 litre of normal saline in the 
first hour). The serum sodium, state of hydration and urinary output should guide the choice and rate of subsequent 
fluid replacement. Patients with renal or cardiac comorbidities should be closely monitored to avoid fluid 
overload. 
Insulin regimes and potassium replacement guides are similar than for DKA. As HHS typically present in elderly 
patients who are likely to have comorbidities, additional emphasis should be placed on monitoring for 
hypoglycaemia and electrolyte abnormalities to limit the more detrimental effect than expected in younger 
healthier patients.[3,38,43] 
Resolution 
The resolution of HHS is defined as a normalised serum osmolality (< 320 mOsm/kg) together with an 
improvement in the patient’s mental state.[10] Longer periods of time are compared to DKA.[33,38,51] One study 
reported a resolution time of 11 hours, while another study reported a time to resolution of  
29 ± 20.6 hours.[44,45] 
Mortality 
HHS is associated with a considerably higher mortality rate than DKA since it occurs more frequently in older 
patients with underlying comorbidities.[38] A Taiwanese study documented a mortality rate of 24%, with the 
degree of depressed level of consciousness associated with mortality.[57] Even higher mortality rates have been 




Uncomplicated hyperglycaemia is strictly not defined as a diabetic emergency. These patients may be 
encountered early in the course of their DKA or HHS, and thus have not yet developed acidosis or 
hyperosmolarity, or they may be chronically hyperglycaemic. However, it is associated with increased hospital 
mortality in both critically ill patients and in patients admitted to general hospital wards.[59] Many such patients 
also present to the emergency centre and is therefore shortly described. 
Definition 
Uncomplicated hyperglycaemia is defined as a fasting glucose level of >7 mmol/L or a random blood glucose 
level of >11.1 mmol/L, in the absence of DKA, HHS, and any neurological symptoms or signs. If ketonaemia is 




The prevalence of uncomplicated hyperglycaemia is expected to rise along with the global rise in diabetes.[61] 
The prevalence varies, from 38% in the US to 42% in North Sudan.[59,62] 
Risk factors 
Risk factors involved in hyperglycaemia are the same as for DKA and HHS and typically includes genetic 
predisposition, advanced age and factors associated with a sedentary lifestyle (smoking, obesity, physical 
inactivity).[3] 
Clinical presentation 
Patients presenting with symptomatic uncomplicated hyperglycaemia typically present with polyuria, polydipsia, 
rapid weight loss, blurred vision, or suspicious infections (e.g. significant yeast infections, abscesses, anaerobic 
infections and foot infections.).[10,63,64] Other non-specific complaints may include fatigue and weakness. Patients 
may also be dehydrated as a result of the osmotic diuresis. Unless the patient suffered a stroke, there should be 
no neurological abnormality and patients are generally well appearing. 
Management 
The main management goals should be to ensure adequate rehydration, to manage any comorbidities or 
precipitating causes and to return the patient to a euglycaemic state. The management of the hyperglycaemia can 
be accomplished by either continuous insulin infusion or subcutaneous insulin use.[61] In-hospital teams manage 




Hypoglycaemia has historically been characterized by a triad of symptoms consistent with hypoglycaemia, a low 
blood glucose level, and relief of hypoglycaemic-symptoms when the blood glucose level has been raised.[65] 
The ADA categorised hypoglycaemic episodes as i) Severe hypoglycaemia, ii) Documented symptomatic 
hypoglycaemia, iii) Asymptomatic hypoglycaemia, iv) Probable symptomatic hypoglycaemia, and v) Relative 
hypoglycaemia.[65] The review will focus on the first two categories: severe hypoglycaemia and documented 
symptomatic hypoglycaemia. 
Severe hypoglycaemia, as defined by the ADA, is “an event requiring the assistance of another person to actively 
administer carbohydrate, glucagon’s, or other resuscitative actions.”[65] Blood glucose levels might not always be 
available as patients often present with seizures or coma; however, neurological recovery after correction of the 
blood glucose level is deemed sufficient evidence that the episode was a result of neuroglycopenia. On the other 
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hand, documented symptomatic hypoglycaemia occurs in patients with a measured blood glucose level <3.9 
mmol/L, presenting with typical symptoms of hypoglycaemia.[65] 
Prevalence 
The true prevalence of hypoglycaemia is difficult to attain, as a large portion of patients are trained to recognise 
its effects and correct the hypoglycaemic state without presenting to hospital. Several self- reported both 
internationally and locally driven studies have shown variable prevalence, from 30% up to 90%.[20,66,67] A 
Denmark study indicated that 36% of T1DM patients had experienced severe hypoglycaemia at some point in 
their lives.[68] Despite the high self-reported prevalence an overall decline in hypoglycaemic linked admissions 
was seen in the US (1.8 to 1.4 per 100 adults) from 2006– 2011.[69] In South Africa, 51 episodes of hypoglycaemic 
have been observed in 43 patients over a 5- month period.[70] 
Risk factors 
Hypoglycaemia is an expected complication in diabetic patients. The associated risk factors include 
hypoglycaemic unawareness, aggressive glycemic therapy, recent moderate or intense exercise, sleep, and renal 
failure.[65] 
Mild hypoglycaemic episodes frequently precede severe hypoglycaemia and analysing self-monitored glucose 
data over time can be used to predict severe hypoglycaemia.[71,72] 
Both T1DM and T2DM are at risk of developing hypoglycaemia. The prevalence of severe hypoglycaemia in 
T2DM in a meta-analysis of population-based studies was 6%.[66] In South Africa, hypoglycaemia was 
experienced in 49% of T1DM patients and 68% among T2DM patients over a four- week period.[20] 
The treatment regime also affects the risk of severe hypoglycaemia. In T2DM, the prevalence of severe 
hypoglycaemia in patients on insulin was 21%, compared to 5% for those that took a sulphonylurea.[66] 
The elderly are predisposed as a result of their impairment of autonomic responses, as well as underlying organ 
dysfunction due to ageing.[69,73,74] Frail persons, those using multiple medications, and those who are frequently 
hospitalized are at highest risk for drug-associated hypoglycemia[75] 
The association between increased HbA1C level and hypoglycaemia is controversial, although an increased level 
has been associated with an increased risk.[67,76] Lastly, comorbidities such as chronic kidney disease increase 
the risk for hypoglycaemia by 27%.[77,78] 
Clinical presentation 
Hypoglycaemia typically presents with either autonomic (diaphoresis, nausea, palpitations and anxiousness) or 
neuroglycopenic symptoms (dizziness, confusion ,cognitive impairment, seizure and coma).[79] The former tends 
to occur at glucose levels above 3mmol/L and the latter at glucose levels less than 2,8mmol/L.[80] A decreased 
level of consciousness occurred in over 60% of patients presenting with hypoglycaemia in India,[81] whereas 70% 




Hypoglycaemia can be a consequence of poor dietary intake, comorbidities, infection and diabetic treatment 
itself.[66,79,82]Infection is a key precipitant for hypoglycaemia, with one study reporting an infection rate of 
55%.[82] Specifically infections of urinary (33%) and respiratory origin (23%) were frequent.[82] 
Other associated precipitants are inadequate dietary intake and alcohol use. Poor dietary intake accounted for 
36% and the use of alcohol for 22% of admissions in hypoglycaemic patients in a South African study. [70] 
Risk factors in patients with recurrent hypoglycaemic episodes include: Inappropriate treatment, poor adherence 
to treatment, alcohol abuse, self-induced hypoglycaemia, Renal and liver disease, hypoglycaemia unawareness, 
drug interactions, and non-diabetic causes of hypoglycaemia e.g. insulinoma.[37] 
Management 
The management of hypoglycaemia involves attaining euglycemia (blood glucose level 4-7 mmol/L). 
Symptomatic patients can self-correct the hypoglycaemia by ingesting a carbohydrate.[65] Patients with severe 
hypoglycaemia will need intravenously administered dextrose.[37] Finding and treating the cause for 
hypoglycaemia should be a priority in its management.[37,73] Individualized management approaches to prevent 
future hypoglycaemic episodes needs to be put in place. Patients with recurrent hypoglycaemic episodes should 
be referred to a specialist endocrine facility.[37] 
Mortality 
Hypoglycaemia in diabetic patients is associated with the risk of death. In T1DM, up to 6% of all deaths have been 
attributed to hypoglycaemia, and around 9% in T2DM receiving sulfonylurea monotherapy.[83] Patients with 
severe hypoglycaemia had 3.4-fold higher 5-year mortality rate than those who presented with mild 
hypoglycaemia.[76] 
 
Burden of diabetic emergencies on the emergency centre 
Patients with poorly controlled diabetes frequently present to the emergency centre for care. Limited access to 
primary health care facilities, low socioeconomic status, poor adherence to treatment, and predisposition to 
certain conditions are factors that increase the frequency of emergency centre visits.[10,69,84,85] Additionally, the 
emergency centre is often the sole provider for diabetic care. A US- based study reported that more than 50% of 
diabetic patients who presented to the emergency centre, where exclusively managed by emergency centre 
staff.[86] 
Patients with a hyperglycaemic crisis often presents to the emergency centre. In Canada, about 17 patients are 
treated monthly for hyperglycaemic emergencies in the emergency centre.[64] Similarly in the US, 0.9 of every 
100 adults seen in the emergency centre relates to a hyperglycaemic crisis.[69] Also of note, is that 17% of patients 
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that presented with a hyperglycaemic crisis visited the emergency centre during the previous 14 days.[85] In South 
Africa, 10 patients presented monthly with DKA to a regional hospital in the KwaZulu/Natal province.[17] 
Severe hypoglycaemic episodes are also frequently encountered in the emergency centre. In the US, 1.4 per 100 
adult emergency centre visits were due to hypoglycaemia, despite the frequency having decreased by 22% over 
a 5-year period.[69] Patients who experienced hypoglycaemic episodes are also likely to revisit the emergency 
centre, with 5% returning within 48 hours after their initial presentation.[87] Data regarding hypoglycaemic 
episodes in South African emergency centres are lacking. 
The burden of diabetic emergencies on emergency centres is high. These patients usually require intense 
monitoring that should be provided in a high care or intensive care unit. In resource-limited settings, these 
patients are managed in the emergency centre till complete resolution as the emergency centre is often the only 
place equipped to provide continuous monitoring (except for the theatre-complex).[41] The mean length of stay 
in the emergency centre of DKA patients in South Africa was 1.5 (±0.8) days.[17] This prolonged stay within the 
emergency centre often creates bed shortages.[31] 
 
Conclusion 
The expected increase in diabetes prevalence in LMICs are evident. The economic effect of diabetes and its 
complications is major, considering that most patients are part of the economically active group. This necessitates 
the need for prevention, early detection and avoiding of microvascular and macrovascular complications of 
diabetes, which, inadvertently increase the risk for hospitalisation and decreases the quality of life. Despite the 
currently low prevalence in Africa, diabetes is a significant contributor to mortality.[10,12] 
The global burden of diabetic emergencies is substantial. Management strategies are effective, but resource 
intensive. This become problematic in lesser resourced settings where prolonged care is often provided in the 
emergency centre. The exact burden of diabetic emergencies on South African emergency centres is not well-
known, and no studies were reported from entry-level hospitals. A better understanding of the burden will 
potentially identify setting specific risk factors that might be amenable to prevention strategies to decrease the 
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Diabetes and its complications continue to cause a daunting and growing concern on resource-limited 
environments. There is a paucity of data relating to the care of diabetic emergencies in the emergency centres of 
entry-level hospitals in Africa. The aim of this study was to describe the burden of diabetic emergencies 
presenting to the emergency centre of an urban district-level hospital in Cape Town, South Africa. 
Methods 
The Khayelitsha Hospital Emergency Centre database was retrospectively analysed for patients presenting with 
a diabetic emergency within a 24-week randomly selected period. The database was supplemented by a 
retrospective chart review to include additional variables for participants with diabetic ketoacidosis (DKA), 
uncomplicated hyperglycemia, severe hypoglycaemia and hyperosmolar hyperglycaemic state (HHS). Summary 
statistics are presented of all variables. 
Results 
The prevalence of all diabetic emergencies was 8.1% (197/2424) (DKA n=96, 48.7%; uncomplicated 
hyperglycaemia n=45, 22.8%; severe hypoglycaemia n=44, 22.3%; HHS n=12, 6%). The median age was 48 
years, with those presenting with DKA being substantially younger (36 years). A likely precipitant was identified 
in 175 (88%) patients; infection was the most common precipitant (n=79, 40.1%). Acute kidney injury occurred 
in 80 (40.6%) cases. The median length of stay in the resuscitation area was 13 hours (IQR 7.2-24) and 101 
(51.3%) participants represented with a diabetic- related emergency within six months of the study period. The 
overall mortality rate was 5% (n=10). 
Conclusion 
This study highlights the high burden of diabetic emergencies on the provision of acute care at a district- level 
hospital. The high prevalence of diabetic emergency presentations (8%), the high infection rate (40%), and the 
high percentage of patients returning with a diabetic emergency (51%) could be indicative of the need for 









Diabetes is a significant contributor to morbidity and mortality and remains a global health concern. An estimated 
382 million people had diabetes in 2013, and this number is expected to double by 2035; the majority of this 
increase is expected in low-and middle-income countries.[1] The World Health Organization further projects that 
diabetes will be the seventh leading cause of death in 2030.[2] In South Africa, an estimated 7% of economically 
active citizens have diabetes, and along with other non- communicable diseases, pose a major socio-economic 
threat to South Africa.[3,4] 
Diabetes is globally one of the most prevalent chronic diseases amongst emergency centre patients,[5,6] and 
patients often present with a diabetic emergency (diabetic ketoacidosis (DKA), hyperosmolar hyperglycaemic 
state (HHS), uncomplicated hyperglycaemia and severe hypoglycaemia). Patients with diabetic emergencies 
should ideally be treated in intensive care or high care settings,[7] but this may not always be possible.[8] As a 
result, these acutely ill patients are often treated for extended periods in the emergency centre.[9] This places 
undue strain on emergency centre staff and resources, as these patients require precise monitoring and ongoing 
management.[7] 
There is currently a paucity of data about the burden of diabetic emergencies on emergency centres at entry-level 
hospitals, as most studies focussed on intensive or high care units within well-resourced countries. South Africa 
has a mounting burden of diabetes and other non-communicable diseases,[10] and knowledge of the burden of 
diabetic emergencies within the local context is essential as part of the effort to reduce diabetic-related morbidity 
and mortality. The study set out to describe the burden of diabetic emergencies on the emergency centre of a 
district-level hospital in Cape Town, South Africa. 
Methods 
Study design 
A retrospective analysis of a prospectively collected observational database was conducted at Khayelitsha 
Hospital covering a period of 24 randomly selected weeks between 1 January 2017 and 30 June 2018. The 
database was supplemented by a retrospective chart review to include additional variables. The study was 
approved by the Health Research Ethics Committee of Stellenbosch University (S18/10/215). The STROBE 
(Strengthening the Reporting of Observational Studies in Epidemiology) checklist was used to guide the 
report.[11] 
Study setting 
Khayelitsha Hospital is a 340-bed hospital situated in the partially informal township of Khayelitsha, Cape Town. 
It serves a health district with a population just fewer than 500 000 people; a substantial proportion of which are 
unemployed (38%).[12] The resuscitation area within the emergency centre consists of four adult-sized beds and 
one paediatric/neonatal resuscitation cot. Each bed is individually equipped with non-invasive and invasive 
monitoring tools, a fully stocked resuscitation trolley, a ventilator, and a defibrillator. A blood gas machine is 
Stellenbosch University https://scholar.sun.ac.za
27 
also situated within the resuscitation area. Patients managed within the resuscitation area are selected based on a 
high acuity level on the South African Triage Scale or by a senior physician’s clinical gestalt.[13] Other than 
theatre, the resuscitation area is the only place capable of continuous patient monitoring, as the hospital does not 
have a high care or intensive care unit. 
Data collection and management 
The Khayelitsha Hospital Emergency Centre database is a prospectively collected observational database and 
has previously been described.[6] In brief, data is captured electronically, is coded and stored onto a password-
protected server. A decoding sheet is separately stored. The database has been registered at the Stellenbosch 
University Health Research Ethics Committee (Ref: N15/10/107) 
Convenience sampling was used, and 24 weeks within 18 months was randomly selected (using a computer 
randomizer). The sample size was limited due to restricted resources; however, it was expected to be 
representative of the population. All patients who presented to the resuscitation area with a diabetic emergency 
(DKA, HHS, uncomplicated hyperglycaemia or hypoglycaemia) were eligible. Patients presenting with 
uncomplicated hyperglycaemia were included as many patients with elevated glucose levels are unable to 
produce urine at triage. These patients are often severely ill despite well looking and true hyperglycaemic 
emergencies (DKA, HHS) have previously been missed. All patients with elevated or decreased glucose levels 
are thus managed within the resuscitation area until a senior clinician have evaluated the patient. Patients who 
presented with a diabetic emergency in the absence of pre-existing or newly diagnosed diabetes were excluded 
(e.g. hyperglycaemic stress response). Patients with missing folder numbers or medical notes were also excluded. 
Diabetic emergencies were defined using criteria from the American Diabetes Association (ADA) and the 
Society for Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA).[7,14] DKA was defined as 
hyperglycaemia with glucose >13.9 mmol/l, metabolic acidosis with pH <7.3 and bicarbonate <18 mmol/l, and 
presence of ketonemia (>3 mmol/l). As serum ketones were not readily available, the presence of urine ketones 
was used as a surrogate marker when indicated. The serum pH was used to classify severity: mild (7.25 - 7.3), 
moderate (7.0 - 7.24), severe (<7.0). Resolution of acidosis (pH >7.3, bicarbonate >18 mmol/l) and ketonemia 
(<3 mmol/l) were used to determine the resolution of DKA. severe hyperglycaemia (serum glucose >33.3 
mmol/L), hyperosmolality (serum osmolality >320 mOsm/kg), marked dehydration and the absence of 
significant acidosis (pH> 7.3, bicarbonate >15 mEq/L); ketonuria may be slight or absent. Uncomplicated 
hyperglycaemia was defined as random blood glucose >11.1 mmol/l in the absence of ketonemia and acidosis. 
Hypoglycaemia was defined as a blood glucose level <3.9 mmol/l with an altered level of  consciousness. 
The Triage Early Warning Score (TEWS) was used to determine patient acuity. The TEWS is a composite score 
of physiologic parameters measured at arrival to the hospital. It forms part of the South African Triage Scale and 
categorizes patients as non-urgent (green), urgent (yellow), very urgent (orange), and emergency (red).[13] 
Data was collected after a decoded cleaned extract of the electronic database has been obtained (cleaned: copied 
into an Excel spreadsheet with all non-diabetic emergencies removed). The password- protected Excel 
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spreadsheet was further populated using the hospital’s electronic clinical records. Data collected include 
diagnosis, demographic profile, clinical presentation, precipitating factors, comorbidities, biochemical profile, 
diagnostic tests performed, interventions received while in the resuscitation area, length of stay in the 
resuscitation area, length of hospital stay, disposition from resuscitation area, and in-hospital mortality. Patient 
folder numbers, the primary identifier used in the database was removed once the entire data collection was 
complete. A pilot study was conducted on 10 participants to standardise data abstraction (data were included). A 
single data collector, not blinded to the study’s objective, collected the data. 
Data analysis 
Incomplete data points were excluded from the analysis. Summary statistics were used to describe all variables. 
Categorical data were summarised using frequency counts or percentages, and distributions of variables were 
presented as two-way tables. Medians and means were used as the measures of central tendency for ordinal and 
continuous responses and standard deviations or quartiles as indicators of spread. Analysis was performed using 
Microsoft® Excel for MAC Version 16.30(19101301). 
Results 
A total of 197 patients with a diabetic emergency were included after 26 cases were excluded. The prevalence 









Demographic details of participants are given in Table 1. Most participants were female (n=113, 57.4%). The 
median (25th - 75th percentile) age was 48 (31-62) years, with participants diagnosed with DKA being 
substantially younger (36 (25-46) years). The majority of the participants (n=135; 68.5%) had type 2 diabetes, 
and overall, 31 (15.7%) was newly diagnosed with diabetes. A total of 135 (68.5%) participants presented outside 
regular office hours (weekdays 08h00-15h59) and 101 (51.3%) represented with a diabetic-related emergency 
within six months; 60 (59.4%) re-presenting within 30 days. The median (25th – 75th percentile) age for re-
presenters in this study was 48 (29-61) years. Most were T2DM (n=70; 69.3%), 66 (65.3%) on insulin, and 32 
(31.7%) on oral anti-diabetic agents. The main precipitants identified were infection (n=40; 39.6%) and non-
compliance (n=25; 24.7%). The in-hospital mortality rate amongst the re-presenters was 6.9 %. 
 Participants included (n=197) 
 
  Diabetic ketoacidosis (n=96) 
  Uncomplicated hyperglycaemia (n=45) 
  Hypoglycaemia (n=44) 
  Hyperosmolar hyperglycaemic state (n=12) 
Excluded (n=26) 
 
  No underlying diabetes (n=10) 
  Double entry (n=8) 
  No notes available (n=6) 
  No folder number (n=2) 
 





Patients managed in the 
resuscitation area over the 





Table 1. Demographic details of patients admitted with a diabetic emergency to the resuscitation area of 
Khayelitsha Hospital 
 DKAa HHSb Uncomplicated Severe Overall 
(n=96) (n=12) hyperglycaemia hypoglycaemia (n=197) 
n (%) n (%) (n=45) (n=44) n (%) 
  n (%) n (%)  
Male 48 (50%) 7 (58.3%) 17 (37.8%) 12 (27.3%) 84 (42.6%) 
Median age (years) 
(Q1-Q3)c 
36 (25-46) 63 (56-71) 54 (44-63) 62 (54-70) 48 (31-62) 
New diabetic diagnosis 19 (19.8%) 4 (33.3%) 8 (17.8%) 0 31 (15.7%) 
Type of diabetes      
Type 1 48 (50%) 0 4 (8.9%) 2 (4.5%) 54 (27.4%) 
Type 2 43 (44.8%) 12 (100%) 39 (86.7%) 42 (95.4%) 136(69%) 
Unknown  5(5.2%) 0 2(4.4%) 0 7 (3.6%) 
Transported by      
Self 22 (22.9%) 1 (8.3%) 8 (17.7%) 12 (27.3%) 43 (21.8%) 
Ambulance 58 (60.4%) 9 (75%) 33 (73.3%) 26 (59%) 126 (63.9%) 
Unknown 16 (16.7%) 2 (16.7%) 4 (8.9%) 6 (13.6%) 28 (14.3%) 
Transported from:      
Home 44 (45.8%) 4 (33.3%) 20 (44.4%) 37 (84%) 105 (53.3%) 
Other health facility 39 (40.6%) 7 (58.3%) 21 (46.7%) 2 (4.5%) 69 (35%) 
Unknown 13 (13.5%) 1 (8.3%) 4 (8.9%) 5 (11.4%) 23 (11.6%) 
Presenting time      
Office hoursd 32 (33.3%) 4 (33.3%) 18 (33.3%) 8 (18.2%) 62 (31.5%) 
After hours 64 (66.7%) 8 (75%) 27 (60%) 36 (81.8%) 135 (68.5%) 
Participant mobility      
Walking 33 (34.4%) 2 (16.7) 18 (40%) 3 (6.8%) 56 (28.4%) 
With Help 46 (47.9%) 4 (33.3%) 21 (46.7%) 13 (40.9%) 84 (42.6%) 
Stretcher/immobile 14 (14.5%) 6 (50%) 6 (13.3%) 28 (63.6%) 54 (27.4%) 
Unknown 3(3.1%) 0 0 0 3 (1.6%) 
Participant acuitye      
Non-urgent (green) 5 (5.2%) 0 2 (4.4%) 0 7 (3.5%) 
Urgent (yellow) 20 (20.8%) 1 (8.3%) 0 9 (20.5%) 30 (15.2%) 
Very urgent (orange) 39 (40.6%) 8 (75%) 2 (4.4%) 14 (31.8%) 63 (32%) 
Emergent (red) 8 (8.3%) 2 (16.7%) 0 15 (34%) 25 (12.7%) 
Unknown 24 (25%) 1 (8.3%) 41 (91.1%) 6 (13.6%) 72 (36.5%) 
a Diabetic Ketoacidosis, b Hyperosmolar hyperglycaemic state, c 25th percentile to 75th percentile, d Monday to 
Friday (08h00 – 15h59), e According to Triage Early Warning Score (TEWS) of the South African Triage Scale 
(SATS) 
 
Gastrointestinal symptoms, which includes at least one of either nausea, vomiting, abdominal pain and/or 
diarrhoea, occurred in most patients (n=143, 72.6%). Infection and poor drug compliance were the most frequent 
precipitants (79 (40.1%) and 52 (26.4%) respectively). Most infections related to the respiratory tract (n=23; 
29.1%), and the gastro-intestinal system (n=15; 19%). Other infections included soft tissue infections (n=12; 
16%), urinary tract infections (n=11; 15%), undefined sepsis (n=8; 10%), central nervous system infections (n=5; 
6.3%) and gynaecological infections (n=3; 4%). In hypoglycaemic only participants, infection (n=15; 34%), 
overmedication with prescribed hypoglycaemic agents (sulphonylureas and insulin)(n=11, 25%), inadequate 




Table 2. Precipitants, presenting symptoms and comorbidities in patients admitted with a diabetic emergency to 

















86  (89.6%) 10 (83.3%) 37 (82.2%) 43 (97.7%) 175(88.8%) 
Precipitant      
Infection 36 (37.5%) 7 (58.3%) 21 (46.7%) 15 (34%) 79 (40.1%) 
Non-
compliance 
38 (39.6%) 2 (16.7%) 12 (26.7%) 0 52 (26.4%) 
Medication 
related 
2 (2%) 0 0 11 (25%) 13 (6.6%) 
Alcohol related 7 (7.3%) 0 0 1 (2.3%) 8 (4%) 
Diet related 2 (2%) 0 0 9 (20.5%) 11 (5.6%) 




     
Gastrointestinal 
symptoms 





1 (8.3%) 7 (15.5%) 0 22 (11.2%) 
Lethargy 2 (2%) 0 0 2 (4.5%) 4 (2%) 
Shortness of 
breath 
19 (19.8%) 0 4 (8.9%) 4 (9%) 27 (13.7%) 
Weakness 32 (33.3%) 6 (50%) 18 (40%) 4 (9%) 57 (28.9) 
Altered level of 
consciousness 
14 (14.6%) 10 (83.3%) 3 (6.7%) 26 (59%) 53 (26.9%) 
Comorbidities      
Hypertension 31 (32%) 10 (83.3%) 28 (62.2%) 34 (77.3%) 103 (52.3%) 
Chronic kidney 
disease 
3 (3.1%) 2 (16.7%) 2 (4.4%) 7 (15.9%) 14 (7.1%) 
 
HIVc positive 19 (19.8%) 0 6 (13.3%) 7 (15.9%) 32 (16.2%) 
Alcohol 
abuse/binge 
11 (11.4%) 0 0 1 (2.3%) 12 (6%) 
Macrovascular 
complicationsd 
5 (5.2%) 3 (25%) 10 (22.2%) 10 (22.7%) 28 (12.7%) 
Microvascular 
complicationse 
20 (20.8%) 7 (58.3%) 9 (20%) 19 (43.1%) 55 (27.9%) 
a Diabetic Ketoacidosis, b Hyperosmolar hyperglycaemic state, c Human immunodeficiency virus, d Includes 




The investigations performed and treatment given are reported in Table 3. In total, 60 serum ketone tests were 
done of which 38 (63%%) were found to be positive. In the DKA group, 41 patients had a serum ketone test 
with urinary dipsticks used to diagnose 55 patients. Twenty (10.1%) of the 62 urine cultures sent were positive; 
the most common organisms were Escherichia coli (n=5) and Klebsiella pneumoniae (n=5). A total of 77 blood 
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cultures were sent and 16 (21%) were positive; coagulase-negative staphylococcus was identified as the most 
common organism (n=6), followed by Klebsiella pneumoniae (n=2) and Escherichia coli (n=2). The median 
(25th – 75th percentile) amount of fluid given in all patients was 3.9 (2.0-5.6) litre, and 72 (37%) patients received 
antibiotics (Table 3.) 
 
Table 3. Investigations done and treatment given for patients with a diabetic emergency managed in the 
resuscitation area of Khayelitsha Hospital 












Overall (n=197) n 
(%) 
Antibiotics 39(40.6%) 7(58.3%) 13(28.9%) 13(29.5%) 72(37%) 
Blood culture 50(52%) 10(83.3%) 8(17.8%) 9(20.4%) 77(39%) 
Blood gas 94(97.9%) 12(100%) 45(100%) 35(79.5%) 186(94.4%) 
Bolus insulin /sliding 
scale 
16(16.7%) 1(8,3%) 36(80%) 1(2.3%) 54(27.4%) 
Chest x-ray 88(91.7%) 12(100%) 38(84.4%) 39(88.6%) 177(89.3%) 
Electrocardiogram 73(76%) 12(100%) 21(46.7%) 24(54.4%) 130(65.9%) 
Insulin infusion 78(81.3%) 11(91,7%) 4(8.9%) 1(2.3%) 93(47.2%) 
Intravenous fluids 88(91.7%) 12(100%) 28(62.2%) 28(63.6%) 156(79.2%) 
Investigations      






1.9 (1.0-2.25) 1.7 (1.0-2.0) 3.9 (2.0- 
5.6) 
Positive blood culture 9(18%) 3(30%) 0 4(44.4%) 16(20.8%) 
Positive for pulmonary 
tuberculosis 
2(50%) 0 2(66.7%) 0 4(57.1%) 
Positive urine culture 11(28.9%) 2(28.6%) 3(37.5%) 4(44.4%) 20(32.3%) 
Serum ketones 40(41.7%) 5(41.7%) 13(28.9%) 1(2.3%) 59(29.9%) 
Sputum testing for 
pulmonary tuberculosis 
(Xpert MTB/RIF) 
4(4.2%) 0 3(6.7%) 0 7(3.6%) 
Treatment      
Urine culture 38(39.6%) 7(58.3%) 8(17.7%) 9(9%) 62(31.4%) 
Urine dipstick 78(81.3%) 8(66.7%) 41(91.1) 9(20.4%) 136(69%) 
a Diabetic Ketoacidosis, b Hyperosmolar hyperglycaemic state, c 25th percentile to 75th percentile 
 
 
A summary of laboratory investigations are presented in Supplementary Table 1. Acute kidney injury occurred 
in 80 (40.6%) cases; 48 (60%) in the DKA group, 18 (23%) in the uncomplicated hyperglycaemia group, and 8 
(10%) in the HHS group. Six (13.6%) of the hypoglycaemic cases had acute kidney injury. Hyperkalaemia 
(potassium >5 mmol/L) occurred in 34 (22.2%) of all hyperglycaemic cases and hypokalaemia (potassium <3 
mmol/L) in 7 (4.6%) cases. 
The median time spent in the resuscitation area was 8.4 hours, with the longest times shared between patients 
with DKA and HHS (Table 4). Patients spent a median of 3.2 days in the hospital (Table 4). In-hospital teams 
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managed 123 (62.4%) of the patients, with 20 (9.8%) of the patients transferred for tertiary care. The in-hospital 
mortality during the study period was 5.0% (n=10; DKA n=1; HHS n=2; severe hypoglycaemia n=7). Only one 
death occurred in the resuscitation area. While most deaths occurred in the hypoglycaemic group (n=7, 70%), 
the actual cause of death mainly related to an intracranial event (n=3, 30%) or undefined sepsis (n=4; 40%). 
 
 
Table 4 Length of stay and disposition of patients managed with a diabetic emergency in the resuscitation area 
















Median length of stay 
(Q1-Q3)c 
     
Resuscitation area 13 (7.2-24) 18 (7.2-24) 5 (2.4-9.6) 5 (2.4-7.2) 8.4 (3.8-18) 
(hours)      
Hospital (days) 4.4 (2.1-7.6) 6.9 (5.3-8.9) 1.1 (0.5-4.0) 1.8 (0.8-5.4) 3.2(0.9-6.3) 
Disposition      
Discharged directly 
home 
15 (13.5%) 0 24 (53.3%) 20 (45.4%) 57 (28.9%) 
Referred to in-hospital 
disciplines 
74 (77%) 10 (83.3%) 18 (40%) 21 (47.7%) 123 (62.4%) 
Referred to tertiary 
facility 
7 (7,3%) 2 (16.7%) 3 (16.7%) 2 (4.5%) 14 (7.1%) 
Died in resuscitation 
area 
0 0 0 1 (2.3%) 1 (0.5%) 




The prevalence of diabetic emergencies (8%) is indicative of the high burden on the resuscitation area of 
Khayelitsha Hospital. Almost half of the presentations related to DKA and urine dipsticks were mainly used to 
assess for ketosis. Infection was the main precipitant in all groups (40%). The high percentage of patients (51%) 
returning with a diabetic emergency to the emergency centre within six months is of concern and further 
increases the burden. 
The prevalence of hyperglycaemic emergencies was 6.3% and 4.5% for DKA and HHS combined (i.e. 
uncomplicated hyperglycaemia excluded). This equates to about 18 patients per month, which is similar to a 
Canadian emergency centre where 17 patients with hyperglycaemic emergencies were treated.[15] However, the 
majority of patients had DKA (about 16 per month), which is substantially more than the ten patients per month 
with DKA seen in the emergency centre of a rural regional hospital in the KwaZulu/Natal province of South 
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Africa.[9] Exact reasons for this difference remains unclear but could relate to geospatial differences (urban vs 
rural)in diabetes in general.[16,17] 
More than 30% (60/197) of the participants returned within 30 days to the emergency centre with a diabetic-
related emergency. This is higher than the 19% documented in Canada.[15] Recurrent hyperglycaemia visits 
have been associated with patients <25 years of age, a glucose level >20 mmol/L, being on insulin, and a recent 
visit to the emergency centre for hyperglycaemia.[15] Associated factors in our study still need to be formally 
explored, but it is clear that poorly controlled diabetes cause a great burden on the emergency centre of 
Khayelitsha Hospital as they typically require intensive monitoring, for potentially extended periods of time. 
Returning patients (especially those with DKA) are also at high risk of mortality, as seen in this study and 
prevention of recurrent presentations will thus benefit both the patient and the hospital.[18] 
Severe hypoglycaemic episodes were also regularly encountered in the resuscitation area (1.8 per 100 adults). 
This is similar to the 1.4 per 100 adult emergency centre visits in a US-based study.[19] Patients who experienced 
hypoglycaemic episodes were also likely to revisit the emergency centre; 50% returned within six months 
compared to 5% returning within 48 hours in a US study.[20] Comparative data regarding hypoglycaemic episodes 
in South African emergency centres are lacking, but internationally patients using oral anti-diabetic agents are 
at higher risk to return to the emergency centre than those treated with insulin alone.[20] 
Urinary ketone assessment (using a dipstick) was more frequently used than testing for serum ketones (laboratory 
done) to detect the presence of ketosis in hyperglycaemic patients (urine 127/153, 83%; serum 58/153, 38%). 
The presence of ketones in the urine (ketonuria) is often used as a surrogate marker for serum ketones 
(ketonemia),[7] as serum ketone laboratory tests are more costly and not everywhere readily available. However, 
there are two ketones that play a role in DKA, acetoacetate and beta- hydroxybutyrate, with the latter being the 
predominant ketone in severe untreated DKA. The urine dipstick detects acetoacetate, but beta-hydroxybutyrate 
is not.[21] Point-of-care blood beta- hydroxybutyrate strips are available, although not at Khayelitsha Hospital at 
the time of the study. A US-based study found a similar sensitivity for blood beta-hydroxybutyrate strips and 
urine acetoacetate dipsticks (both 98%) in diagnosing DKA, but blood beta-hydroxybutyrate strips had higher 
specificity (79%) than the urine acetoacetate dipsticks (35%).[22] The decreased specificity of the urine dipstick 
raises concerns of potentially unwarranted medical work-ups as a result of false negative tests. 
Infection was deemed to be the precipitant factor in 40% of patients which confirms the high rate of infection in 
patients presenting with diabetic emergencies.[23–25] This further indicates the need for the diligent search for 
infection, which should include cultures of blood, urine and pulmonary specimens. One in every five blood 
cultures done were positive, while urine cultures had a slightly higher yield (1.5 in every 5). Although only a 
few sputum cultures were collected, more than half (57.1%) was positive for tuberculosis. Diabetics are 
predisposed to infection and increased, and specialised screening programmes should be considered in settings 
with a high tuberculosis prevalence.[26,27] 
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Strengths and limitations 
A strength of the study was the use of a pre-piloted standardized data collection form. However, the results could 
have been affected by various limitations. Firstly, the study reflects the experience at a single urban emergency 
centre with standardised protocols and care should be taken to generalise the results to different settings. The 
retrospective nature of the study led to the reliance on adequate documentation for quality data. Participants 
could have received treatment at referring clinics or from ambulance crews before arrival; this could have led to 
specific parameters being different by the time the patients presented to the hospital. Lastly, included weeks were 
randomly selected from the existing database, and seasonal variation could have influenced the prevalence. 
Conclusion 
This study highlights the high burden of diabetic emergencies on the provision of acute care at a district-level 
hospital. The high prevalence of diabetic emergency presentations (8%), the high infection rate (40%), and the 
high percentage of patients returning with a diabetic emergency (51%) could be indicative of the need for 
improved community-based diabetic programmes. Future studies could explore barriers to care, such as 
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Supplementary Table 1.Summary of laboratory investigations done at presentation in patients with a diabetic 




















7.1±0.18 7.2±0.15 7.38±0.06 7.3±0.1 7.2±0.18 
Bicarbonate 
(mmol/L) 
18-28 12.7±8.6 16.6±6.3 23.7±3 21.1±7.9 16.4 ±8.9 
Base excess 
(meq/l) 
-2 to +2 -12.2±11.2 -9.1±8 -0.12±3.8 -3±9.1 -7.3±10.7 
Lactate (mmol/L) <2 3.2±1.9 4.1±3.6 1.98±0.8 2.7±3.2 3±2.4 
















































































Platelets (x 109/L) 186- 
454 
368.4±167.7 271.7±76.9 334±139.8 329.5±116.1 345.8±148.4 
Haemoglobin A1c 
(%) 
<7 13.4±5.6 11.6 ±4.9 12.9±3.2 8.3±2.4 12.1±5.1 
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Diabetes remains a global health concern as it contributes significantly to morbidity and mortality. In 2013 it 
was estimated that 382 million people had diabetes; this is predicted to rise to 592 million by 2035.(1) 
Subsequently, up to 12% of global health expenditure is spent on diabetes and its complications.(2) Diabetes 
mortality rates are as high as 30%,(3) with about 73% of these deaths occurring in the economically active 
group.(4) The World Health Organisation (WHO) projects that diabetes will be the seventh leading cause of 
death in 2030.(5) 
The biggest increase of people living with diabetes is expected to occur in low-and-middle-income countries in 
the next two decades.(1) Recent data suggest that 7% of economically active South Africans have diabetes. This 
means that 3.85 million people between the ages of 21 and 79 years may be living with the disease.(2) These 
numbers reflect the mounting burden of non-communicable diseases in South Africa,(6) despite the declaration 
that non-communicable diseases are a focus area on the African continent.(7) Additionally, a large focus is still 
on communicable diseases,(8) despite the major social, economic and psychological threat diabetes poses.(9) 
Patients with hyperglycaemic emergencies should ideally be treated in an intensive care or high care setting.(10) 
This indeed happens in South Africa,(11) but may not always be possible due to a host of reasons, including the 
paucity of freely available intensive care and high beds.(12) As a result, these acutely ill patients often end up in 
the emergency centre of the hospital.(13) 
Diabetes is one of the most prevalent chronic diseases amongst all visitors to the emergency centre, both 
internationally and locally.(14,15) These patients are often managed in the resuscitation area of the emergency 
centre as it often is the only monitored area in the hospital outside of theatre.(14) This is not ideal for both the 
patient and the emergency centre staff as these patients have a mortality rate around 17%.(13) 
Motivation 
Diabetes and its emergency complications (hyper- and hypoglycaemic) are highly prevalent in patients managed 
within emergency centres. Unfortunately, the exact burden remains unknown, especially at the district health 
care level. The purpose of this study is to quantify the burden of diabetic emergencies on the resuscitation area of 
a district-level hospital, and if possible, to identify setting specific risk factors that might be amenable to 
prevention strategies. 
Aim and objectives 
The aim of the study is to determine the burden of the various types of diabetic emergencies on the resuscitation 
area of Khayelitsha Hospital over a six-month period. 
The objectives are: 
i. To determine and describe the prevalence of diabetic emergencies (diabetic ketoacidosis, 
hyperosmolar hyperglycaemic state and hypoglycaemia) 
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ii. To determine precipitant(s) and risk factors for the diabetic emergencies 
iii. To determine and describe the diagnostic tests performed and interventions received while in the 
resuscitation area 
iv. To determine the length of stay in the resuscitation area and in hospital 
v. To determine the in-hospital mortality of the patients 
vi. To determine the prevalence (and possible precipitating factors) of re-admissions relating to diabetic 
emergencies within six months 
Methodology 
Study design 
A retrospective analysis of a prospectively collected observational database will be conducted of a period of six 
months. This will be supplemented by a retrospective chart review to include additional variables. 
Study setting 
Khayelitsha Hospital is a 300-bed hospital situated in the expansive township of Khayelitsha, Cape Town. It 
serves a health district with a population of more than 390 000, which is predominantly Black African (99%) 
with significant levels of unemployment (38%).(16) There is a tremendous burden of disease related to HIV, TB 
and interpersonal violence.(17) 
Khayelitsha Hospital provides inpatient services such as surgical, medical, paediatric and obstetrics.(18) It houses 
a large emergency centre, which is 30% larger than that of a standard district hospital trauma unit.(18) The 
resuscitation area consists of four beds and a paediatric cot. Each equipped with its own monitor containing a 
blood pressure, pulse oximetry, and capnography capabilities. In addition, there is a fully stocked emergency 
trolley for airway management with a defibrillator and a standalone ventilator for each bed. The admission 
criteria are either a high acuity score according to the South African Triage Scale or at any senior practitioner’s 
discretion.(19) With no high care or intensive care beds available at the facility. 
Study population 
The electronic Khayelitsha Hospital Emergency Centre database is a prospectively collected observational 
database capturing all patients managed within the resuscitation area since 1 November 2014. Data are captured 
electronically, are coded and stored onto a password protected server. A decoding sheet is separately stored. The 
database has been registered at the Stellenbosch University Health Research Ethics Committee (Ref: 




A total of 24 weeks will be randomly selected (using a computer randomiser) from the Khayelitsha Hospital 
Emergency Centre database between 1 January 2017 and 30 June 2018. This sample should be representative of 
most confounding variables e.g. seasonal variations. We expect a sample size of ± 150 patients. 
Data collection and management 
A diabetic emergencies will be defined using the definitions of the American Diabetic Association and will 
include the following groups: 
• Diabetic ketoacidosis (DKA): Blood glucose > 13.9mmol/L, presence of serum or urine ketones, anion gap 
> 10, arterial pH < 7.3, serum bicarbonate < 18mmol/l.(20) 
• Hyperosmolar hyperglycaemic state (HHS): Absence of ketones, blood glucose > 33.3mmol/ l, pH > 7.3, 
serum bicarbonate > 20mmol/l and serum osmolarity of 320 mOsm/kg.(20) 
• Hypoglycaemia: Blood glucose < 3.9mmol/l.(21) 
Data will be collected by the investigators on site at Khayelitsha Hospital after a decoded cleaned extract of the 
electronic database has been obtained (cleaned: copied into an Excel spreadsheet with all non- diabetic 
emergencies removed). The Excel spreadsheet will then be further populated through the hospital’s electronic 
clinical record. 
The following variables will be collected: 
• Type of diabetic emergency 
• Patient demographics (Age/ Gender) 
• Patient acuity (according to the South African Triage Scale) 
• Likely precipitant(s) 
• Diagnostic tests performed and their results 
• Interventions received while in the resuscitation area 
• Time spent in the resuscitation area 
• Disposition from the resuscitation area 
• Re-presentation within 6 months after the study period 
• In-hospital mortality 
 
Incomplete data points will be excluded from analysis. A Western Cape Government computer within 
Khayelitsha Hospital Emergency Centre, with a password protected account, will be used for data capture and 
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storage. Patient folder numbers, the main identifier used in the database will be removed and the data 
incorporated with the original database once the entire data collection is complete. The database is stored in an 
internationally recognised, password protected database in the ‘cloud’. The final dataset will not contain patients’ 
names, addresses, folder numbers or other identifying information. A pilot study will be conducted using an 
Excel spreadsheet collecting the data specified above. 
Statistical analysis 
Summary statistics will be used to describe all variables. Categorical data will be summarised using frequency 
counts or percentages, and distributions of variables will be presented as two-way tables or bar charts. Medians 
or means will be used as the measures of central tendency for ordinal and continuous responses and standard 
deviations or quartiles as indicators of spread. Data will be analysed by the research team using Microsoft Excel 
and SPSS statistical software (IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0. 
Armonk, NY: IBM Corp.). A STROBE checklist will be used to structure the final report.(22) 
Time schedule 
• December 2018: SU HREC approval 
• February 2019: Western Cape Government approval 
• March – May 2019: Data collection and management 
• June – July 2019: Data analysis 
• August to October 2019: Write up and submission 
 
Ethical and legal considerations 
Risks and benefits: As this study will not involve direct or indirect patient care, risk to patients is likely minimal. 
The electronic Khayelitsha Hospital Emergency Centre database has already passed through an ethics committee. 
Potential risk due to loss of patient data is however possible. For this reason identifiable data will be removed as 
soon as the data collection for that specific patient is completed. Having a better idea of the specific burden 
related to diabetic emergencies at a mid-level hospital may lead to improved public health practices, improved 
emergency practices and may improve morbidity and mortality. 
Informed consent process: The database from which the initial data will be drawn is registered with the 
Stellenbosch University Health Research Ethics Committee (Ref: N15/10/107) as well as on the National Health 
Research Database (Ref: WC_2014RP10_967). The information obtained from the database will be 
supplemented from the patient record. As this will be retrospective, taking individual consent will be near 
impossible and a disproportionate effort will be needed. We thus request a waiver of informed consent. 
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Privacy and confidentiality: As described earlier, the study will make use of a combination of safeguards to 
ensure anonymity of study subjects. This will include on-site data management using a Western Cape 
Government account and computers, a password protected Excel document containing the data sample, and 
coding data immediately after data collection is completed. 
Limitations 
This is a retrospective study using an existing database and therefor has inherent risks of error. Selection bias is 
primarily a result of either inappropriate inclusion or exclusion of subjects into the database or due to missing 
data. Inclusion criteria for the Khayelitsha Hospital Emergency Centre database is well defined and should not 
lead to any significant error. 
Missing data allow for selection bias by allowing preference for study subjects with complete data. Patients with 
missing data will be reported and will not be excluded from analysis; only the incomplete data points will be 
excluded. Missing patients from the database is also limited since the database manager regularly does quality 
checks to ensure all patients are captured. The nursing register is used for this. 
Data entered into the database may also be imprecise or invalid, resulting in information bias. This is again 
limited by the quality control performed by the database manager. 
Reporting and implementation of results 
Publication as an original article or short report in a peer reviewed journal is anticipated. The study results will 
also be distributed to the management team of Khayelitsha Hospital Emergency Centre. 
Resources 
Resources used will be mainly non-clinical. This will include use of an existing Western Cape Government 
account and computers. As most patient information will be electronically available, Khayelitsha Hospital clerks 
will not be utilised to access hard copy folders. The investigators will not conduct the study when on-duty. The 
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The author guidelines are available at: 
https://www.elsevier.com/wps/find/journaldescription.cws_home/725742?generatepdf=true 
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